Europe Antiviral Drugs Market Size to Cross 8.7 Billion by 2027

According to an estimate, Europe antiviral drugs market size will surpass USD 8.7 billion by 2027. Rising cases of viral infection, including hepatitis, coronavirus, AIDS and respiratory syncytial virus (RSV) infection will underscore Europe antiviral drugs market value. Soaring geriatric demographics will further augment the product adoption. Prominently, elderly population suffering from hypertension, diabetes and CVD are more prone to coronavirus.

An upsurge in the number of drug approvals will augur well for the industry size expansion. The application of anti-viral drugs has played a pivotal role in reducing infection and viral load. Moreover, rising marketing authorization for COVID-19 prescription drugs will further the market presence of drugs. Russia, for instance, gave a green signal for the first COVID-19 drug in September 2020 for sale in pharmacies.
 
Get sample copy of this research report @ https://www.graphicalresearch.com/request/1737/sample
 
Expanding foothold of reverse transcriptase inhibitors following the rise in HIV population will bolster the manufacturing of antiviral drugs in the U.K., Italy, Germany and France. Moreover, rise in FDA approvals has further added impetus towards the product portfolio expansion of the drug. The reverse transcriptase inhibitors segment witnessed over 40% market share in 2020 and will thrive with increasing footprint across the end-use applications.
 
End-users are expected to show increased traction towards branded drugs as they have original drug class which are manufactured and developed through original pharmaceutical company. Besides, bullish demand for branded drugs and an upsurge in research and development activities have come in the backdrop of increased efficacy and specificity.

 
A meteoric rise in hepatitis cases has prompted the manufacturers to up the production of antiviral drugs. According to the WHO, hepatitis incidence rate among the EU members stands at 8.7 per 100,000.  Europe antiviral drugs market revenue from the hepatitis segment surpassed USD 2 billion in 2020 and will grow owing to rise in drug approval across the region.
 
With a spike in geriatric population across the region, industry participants are poised to inject funds in the landscape. According to the Eurostat, over 20% of the EU-27 population are aged 65 years or over. The market share from the geriatric segment in Europe will grow at a considerable rate by 2027.
 
The U.K. is likely to come up as a happy hunting ground in the wake of expansion of healthcare facilities and presence of large patient pool. Prominently, thriving R&D activities and presence of leading companies will underscore the business outlook. Robust approval of drugs and rising drug trial will pan well for industry participants vying to expand their portfolios. Specifically, the U.K. confirmed the roll out of new trial in May 2020 focusing on COVID-19 patients.
 
Stakeholders will expand their presence in Germany on the heels of use of anti-viral medicines for the treatment of infectious diseases, including hepatitis and coronavirus. Notably, surge in baby boomer population has further augmented the demand for anti-viral therapeutics. The American Association of Retired Persons claims that Germany is among the five super-aged societies in the globe. The number of people aged 65 and older is forecast to be pegged at 24 million by 2050 in Germany.
 
 
Europe antiviral drugs market players in the landscape are GlaxoSmithKline, plc, AstraZeneca, Johnson & Johnson, Gilead Science and Merck & Co., among others. These leading companies will further their product lines and up their focus on mergers & acquisitions. Illustratively, Gilead was approached by AstraZeneca for a merger in June 2020.
 
Table of Contents (ToC) of the report:
Chapter 1   Methodology

1.1    Market definitions

1.2    Forecast assumptions

1.3    Data sources

1.3.1    Secondary

1.3.1.1    Paid sources

1.3.1.2    Unpaid sources

1.3.2    Primary

Chapter 2   Market Summary

2.1    Europe antiviral drugs market summary, 2016 – 2027

2.1.1    Country trends

2.1.2    Drug class trends

2.1.3    Indication trends

2.1.4    Type trends

2.1.5    Age group trends

Chapter 3   Market Analysis

3.1    Industry segmentation

3.2    Industry outlook, 2016 - 2027

3.3    Major factor analysis

3.3.1    Growth drivers

3.3.1.1    Increasing prevalence of viral infection

3.3.1.2    Presence of large geriatric population

3.3.1.3    Increasing research and development activities in the field of Anti-viral drugs

3.3.2    Industry pitfalls and challenges

3.3.2.1    Rising awareness about preventive drug treatment

3.3.2.2    Presence of generics

3.4    Analysis of COVID-19 impact on the industry

3.5    Porter’s analysis

3.6    Competitive review, 2020

3.7    PEST analysis

Browse complete Table of Contents (ToC) of this research report @ https://www.graphicalresearch.com/table-of-content/1737/europe-antiviral-drugs-market
 
About Graphical Research:

Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.

Contact Us:
Parikhit B.
Corporate Sales,
Graphical Research
Phone: 1-800-986-6917

Comments

Post a Comment

Popular posts from this blog

3D Scanning Market Share, Trends, Segmentation and Registering a Strong Growth by End of 2027

Image
The 3D scanning market is projected to foresee commendable growth in coming years owing to high product usage across various application avenues such as aerospace & defense, entertainment & media, healthcare, and architecture & engineering among many others. 3D scanning refers to the process of collecting data from the physical object's surface which precisely describes the shape in terms of 3-dimensional space. 3D-based laser scanners are known to measure fine details as well as capture free-form shapes to rapidly generate precise point clouds. Just as 2D-based images are made up of pixels, 3D scans are made up of very tiny polygons or triangles. Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/105 The market for 3D scanning is bifurcated into different segments in terms of product, range, component, application, and regional landscape. With respect to range, the market is classified into long range, medium range, and short ...
Read more

Network Packet Broker Market to Observe Rugged Expansion at a Top CAGR by 2028 End

Image
The network packet broker market is set to exhibit robust growth through 2028 on account of prevalent product adoption in key regions across the globe. A network packet broker refers to a technology that includes a range of monitoring tools, also known as network packets, for accessing and analyzing traffic across a network. The packet broker gathers traffic from multiple network links and filters and distributes every individual packet to the proper network monitoring tool. Through this, these brokers ensure enhanced efficacy from network monitoring & security tools by providing better data from the network. Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/2930 With growing cybersecurity demands, companies are aiming to incorporate virtual traffic, and higher traffic speeds as well as greater complexity of networks have prompted them to identify effective solutions to optimize performance. The integration of network packet brokers to col...
Read more

5G Infrastructure Market Expansion Projected to Gain an Uptick During 2022-2028

Image
The 5G infrastructure market is foreseen to grow enormously through 2028 driven by exponential demand for greater bandwidth and speed capabilities. In addition, increasing government support to promote 5G deployment is primed to further fuel market growth over the forecast timeline. 5G networks provide higher speed bandwidth than existing LTE networks. During the COVID-19 outbreak, the industry witnessed a halt due to safety protocols and lockdowns. However, easing lockdown restrictions have boosted the adoption of wireless technologies, which has enhanced the focus on commercialization of the 5G infrastructure. Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/5258 Furthermore, governments are actively regulating easy market access to equipment for delivering telecom services at reasonable prices to customers. For instance, in May 2022, the Telecommunication Engineering Center (TEC), a technical division of the Department of Telecommunication...
Read more